Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001193125-26-004565

Chief Financial Officer sold 135 shares at $21.41 ($2,890)

  • Chief Financial Officer acquired 374 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Firmani Lori Chief Financial Officer 2026-01-02 Option exercise +374 1,066 D
Firmani Lori Chief Financial Officer 2026-01-02 Sale −135 $21.41 $2,890 931 D
Derivatives
Firmani Lori Chief Financial Officer 2026-01-02 Option exercise · Restricted Stock Units −374 726 D
Open-market sales · 135 sh · avg $21.41 · $2,890
Loading xslF345X05/ownership.xml…